Kazuo Morikawa

631 total citations
57 papers, 503 citations indexed

About

Kazuo Morikawa is a scholar working on Immunology, Materials Chemistry and Mechanics of Materials. According to data from OpenAlex, Kazuo Morikawa has authored 57 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Materials Chemistry and 11 papers in Mechanics of Materials. Recurrent topics in Kazuo Morikawa's work include Metal and Thin Film Mechanics (11 papers), T-cell and B-cell Immunology (11 papers) and Diamond and Carbon-based Materials Research (10 papers). Kazuo Morikawa is often cited by papers focused on Metal and Thin Film Mechanics (11 papers), T-cell and B-cell Immunology (11 papers) and Diamond and Carbon-based Materials Research (10 papers). Kazuo Morikawa collaborates with scholars based in Japan, United States and Bangladesh. Kazuo Morikawa's co-authors include Kazunori Onoé, Ming Yang, Ryoji Yasumizu, Toyo Suzuki, Max D. Cooper, Hiromi Kubagawa, Robert A. Good, Tetsuhide Shimizu, M. Kakinuma and Masahiro Ogasawara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Kazuo Morikawa

54 papers receiving 470 citations

Peers

Kazuo Morikawa
Guiqing Hu United States
Xiang Yao China
W. Kinzy Jones United States
W Ptak Poland
Huilin Tu China
Wenru Liu China
Guiqing Hu United States
Kazuo Morikawa
Citations per year, relative to Kazuo Morikawa Kazuo Morikawa (= 1×) peers Guiqing Hu

Countries citing papers authored by Kazuo Morikawa

Since Specialization
Citations

This map shows the geographic impact of Kazuo Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Morikawa more than expected).

Fields of papers citing papers by Kazuo Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Morikawa. The network helps show where Kazuo Morikawa may publish in the future.

Co-authorship network of co-authors of Kazuo Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Morikawa. A scholar is included among the top collaborators of Kazuo Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Morikawa. Kazuo Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamahara, Hiroyasu, Kazuo Morikawa, Kohei Yamagami, et al.. (2025). Strain‐Induced Reduction of Centrosymmetry in Rare‐Earth Iron Garnet Thin Films. Advanced Electronic Materials. 11(8). 2 indexed citations
2.
Shimizu, Takuto, Yuka Ito, Kazuo Morikawa, et al.. (2021). Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture Cells. Neurochemical Research. 46(8). 2056–2065. 4 indexed citations
3.
Hachiya, Naomi, et al.. (2021). Isomerization of Asp is essential for assembly of amyloid-like fibrils of αA-crystallin-derived peptide. PLoS ONE. 16(4). e0250277–e0250277. 3 indexed citations
4.
Nakao, Shoichiro, Kei Shigematsu, Daisuke Ogawa, et al.. (2020). High mobility approaching the intrinsic limit in Ta-doped SnO2 films epitaxially grown on TiO2 (001) substrates. Scientific Reports. 10(1). 6844–6844. 29 indexed citations
5.
Ogawa, Daisuke, et al.. (2017). Effect of micromorphology on transport properties of Nb‐doped anatase TiO2 films: A transmission electron microscopy study. physica status solidi (a). 214(3). 1 indexed citations
6.
Kawahara, Keisuke, Akira Chikamatsu, Tsukasa Katayama, et al.. (2016). Topotactic fluorination of perovskite strontium ruthenate thin films using polyvinylidene fluoride. CrystEngComm. 19(2). 313–317. 18 indexed citations
7.
Bibert, Stéphanie, Zoltán Kutalik, Kazuo Morikawa, et al.. (2011). 1357 A LARGE-SCALE GENETIC VALIDATION STUDY COUPLED WITH IN-VITRO ANALYSES REVEAL A ROLE OF VITAMIN D-SIGNALING IN THE PATHOGENESIS AND TREATMENT OF CHRONIC HEPATITIS C. Journal of Hepatology. 54. S537–S537. 1 indexed citations
8.
Mitsuo, Atsushi, Masahiro Kawaguchi, Saiko Aoki, Kazuo Morikawa, & Hideto SUZUKI. (2008). Surface Properties on High-Speed Tool Steel Implanted with Methane Plasma. Journal of The Surface Finishing Society of Japan. 59(3). 185–189.
9.
Yang, Ming, et al.. (2006). Fabrication of dies in micro-scale for micro-sheet metal forming. Journal of Materials Processing Technology. 177(1-3). 639–643. 38 indexed citations
10.
Cho, M. W., Kazuo Morikawa, Kenta Arai, et al.. (1997). Surface treatment of znse substrate and homoepitaxy of znse. Journal of Electronic Materials. 26(5). 423–428. 7 indexed citations
11.
Akamatsu, Ken‐ichi, Koichi Endo, Tomoko Matsumoto, et al.. (1992). Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice. British Journal of Cancer. 66(5). 827–832. 8 indexed citations
13.
Akamatsu, Ken‐ichi, Koichi Endo, Tomoko Matsumoto, et al.. (1991). In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II).. PubMed. 11(1). 151–5. 1 indexed citations
14.
Akamatsu, Ken‐ichi, Tomoko Matsumoto, Keiichi Kamisango, et al.. (1990). [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].. PubMed. 17(1). 73–8. 1 indexed citations
15.
Morikawa, Kazuo, et al.. (1990). Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities.. Chemical and Pharmaceutical Bulletin. 38(4). 930–935. 15 indexed citations
16.
Akamatsu, Ken‐ichi, Tomoko Matsumoto, Kazuo Morikawa, et al.. (1989). Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).. PubMed. 9(4). 987–91. 13 indexed citations
17.
Ogasawara, Masahiro, K Iwabuchi, K. OGASAWARA, et al.. (1986). Generation of Cytotoxic T Lymphocyte esponses to Allo-H-2 Antigens in Allogeneic Bone Marrow Chimeras Histocompatible at the H-2 Subregions. Immunobiology. 172(1-2). 128–142. 5 indexed citations
18.
Onoé, Kazunori, Ryoji Yasumizu, Tsutomu Oh‐ishi, et al.. (1981). Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex.. The Journal of Experimental Medicine. 153(4). 1009–1014. 32 indexed citations
19.
Onoé, Kazunori, et al.. (1979). The Study of Difference in the Proportions of FcR+ Lymphocytes between the Spleen and the Lymph Node. Upsala Journal of Medical Sciences. 39(39). 1–5. 1 indexed citations
20.
Takeda, Junko, et al.. (1978). Histological Studies on Adjuvanticity of BCG-Cell Walls--Comparison of adjuvanticity between oil-in-water and water-in-oil forms. Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University). 38(38). 13–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026